Technique and feasibility of a dual staining method for estrogen receptors and AgNORs.
A new staining method for dual demonstration of Estrogen receptors (ER) and argyrophilc Nucleolus-Organizer Regions (AgNORs) was developed. To rule out possible reciprocal effects, serial slides of 10 invasive ductale breast cancers were stained with either the single staining method or the simultaneous ER/AgNOR-staining method and investigated comparatively. By measuring the slides with the image analysis system AMBA, reciprocal effects could be excluded. It was proven that dual staining of both markers results in a reproducible and specific staining result. We concluded that it is justified to measure AgNORs in immunohistochemically stained cells.
Günther
L
L
Department of Surgery, University of Heidelberg, Germany.
Hufnagl
P
P
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D018270:Carcinoma, Ductal, Breast / Q000378:metabolism / Q000473:pathology*; D002452:Cell Count; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D009697:Nucleolus Organizer Region / Q000378:metabolism / Q000648:ultrastructure; D011960:Receptors, Estrogen / Q000032:analysis*; D015203:Reproducibility of Results; D016622:Silver Staining / Q000379:methods
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen